Laura Mauri, M.D., M.Sc., Chief Scientific, Medical, and Regulatory Officer at Medtronic. In this role, Laura leads the global company’s scientific, medical, clinical research and regulatory affairs functions. Her responsibilities include driving the integration of medical and scientific intelligence to inform business decisions and delivering a transformative approach to patient safety and patient engagement.
Laura joined Medtronic in September of 2018 and led the company’s clinical trial response and mitigation plans for COVID-19.
An interventional cardiologist who practiced at the Brigham and Women’s Hospital for 15 years, Laura was an internationally renowned investigator and Professor of Medicine at Harvard Medical School. An expert in trial design, strategy and data analysis, she led numerous clinical trials to evaluate novel medical devices and pharmaceuticals, and held an array of major leadership positions, serving as the Chief Scientific Advisor for the Harvard Clinical Research Institute.
Laura received her A.B. from Harvard College and her M.D. from Harvard Medical School, and her M.Sc. (Clinical Epidemiology) from Harvard School of Public Health. She completed residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at the Brigham and Women’s Hospital.
Laura serves on the Board of directors of Medical Device Innovation Consortium (MDIC) and is a member of the NIH Advisory Committee. She is a member of the American Society of Clinical Investigation, the Association of University Cardiologists, a Fellow of the American College of Cardiology, a Fellow of the American Heart Association and American College of Cardiology, and member of the Society of Cardiac Angiography and Intervention. She has authored approximately 200 original articles, served as a Senior Editor for the journal Circulation, and was awarded the Joseph A. Vita Award for Clinical Research by the American Heart Association in 2017.